
|Videos|June 23, 2023
Introduction to PEComas
Andrew Folpe, MD, provides an overview of PEComas, including their incidence rate and malignant tumors.
Advertisement
Episodes in this series

Now Playing
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Poll Results Reveal Readers’ Top Abstracts at ASH 2025
2
FDA Approves Liso-Cel as First CAR T-Cell Therapy for Marginal Zone Lymphoma
3
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
4
Lurbinectedin Contributes to Maintenance of Response in ES-SCLC
5








































